10/06/2026
From May 27 to 30, 2026, the International Congress of the European Association for the Study of the Liver (EASL) was held in Barcelona, Spain, with live online streaming available. The scientific forum brought together 8,524 delegates from 109 countries worldwide, including 757 participants who attended virtually. The scientific program featured 2,287 abstracts covering all areas of hepatology, practical workshops, expert lectures, and numerous networking opportunities.
The EASL Congress brought together cutting-edge scientific achievements, clinical discussions, translational research, and practical training across the full spectrum of hepatology. Scientific sessions featured some of the most significant research presentations, including new findings on hepatitis B, primary sclerosing cholangitis, metabolic dysfunction-associated steatotic liver disease (MASLD), and hepatocellular carcinoma. Presentations highlighted how advances in therapeutics, disease stratification, and translational research continue to transform clinical practice.
A large proportion of the presentations emphasized the importance of early intervention, precision medicine, and multidisciplinary care. In the field of portal hypertension, discussions focused on non-invasive risk stratification, prevention of decompensation, and optimization of emergency care.
Artificial intelligence and digital innovation were also at the forefront of the congress agenda. Sessions dedicated to generative AI in hepatology explored practical applications ranging from imaging and natural language processing to AI agents and clinical decision-support tools, while also addressing issues of trust, implementation, and future integration into clinical practice.
The scientific program also highlighted progress in the management of liver cancer, portal hypertension, and cirrhosis, including AI-assisted tumor boards, surgical decision-making, vascular liver diseases, and emerging concepts of decompensation and recompensation.
Contact us
📨Email - [email protected]
📲Tel - +380991442141